OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting glutamine metabolism as a therapeutic strategy for cancer
Jonghwa Jin, Jun‐Kyu Byun, Yeon‐Kyung Choi, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 4, pp. 706-715
Open Access | Times Cited: 208

Showing 76-100 of 208 citing articles:

Exploring the metabolic alterations in cervical cancer induced by HPV oncoproteins: From mechanisms to therapeutic targets
Mrudula Gore, Shama Prasada Kabekkodu, Sanjiban Chakrabarty
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189292-189292
Open Access

Glutamine binds HSC70 to transduce signals inhibiting IFN-β-mediated immunogenic cell death
D. H. Zhang, Songze Song, Jing Lin, et al.
Developmental Cell (2025)
Closed Access

Nanomedicines Targeting Metabolic Pathways in the Tumor Microenvironment: Future Perspectives and the Role of AI
Shuai Fan, Wenyu Wang, Wieqi Che, et al.
Metabolites (2025) Vol. 15, Iss. 3, pp. 201-201
Open Access

The emerging role of Sotorasib plus Panitumumab combination therapy in colorectal cancer treatment
Emmanuel Kokori, Gbolahan Olatunji, Ikponmwosa Jude Ogieuhi, et al.
International Journal of Clinical Oncology (2025)
Closed Access

Low extracellular pH protects cancer cells from ammonia toxicity
Maria Dravecka, Ingvild Mikkola, Terje Johansen, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access

Metabolic Dialogue Shapes Immune Response in the Tumor Microenvironment
Fengxia Gao, Rushil Shah, Gang Xin, et al.
European Journal of Immunology (2025) Vol. 55, Iss. 4
Open Access

KRAS-Dependency in Pancreatic Ductal Adenocarcinoma: Mechanisms of Escaping in Resistance to KRAS Inhibitors and Perspectives of Therapy
Enrico Gurreri, Giannicola Genovese, Luigi Perelli, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9313-9313
Open Access | Times Cited: 9

Dietary approaches for exploiting metabolic vulnerabilities in cancer
Otília Menyhárt, Balázs Győrffy
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1879, Iss. 2, pp. 189062-189062
Open Access | Times Cited: 9

The multifaceted roles of small extracellular vesicles in metabolic reprogramming in the tumor microenvironments
Zhixian Chen, Judy Wai Ping Yam, Xiaowen Mao
PROTEOMICS (2024) Vol. 24, Iss. 11
Closed Access | Times Cited: 3

Glutamine metabolism prognostic index predicts tumour microenvironment characteristics and therapeutic efficacy in ovarian cancer
Lingling Gao, Zheng Wei, Feiquan Ying, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 7
Open Access | Times Cited: 3

Mitochondrial enzyme FAHD1 reduces ROS in osteosarcoma
Anne Heberle, Elia Cappuccio, Andreas Andric, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3

Metabolic vulnerabilities in cancer: A new therapeutic strategy
Mohamed El‐Tanani, Syed Arman Rabbani, Yahia El-Tanani, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 201, pp. 104438-104438
Closed Access | Times Cited: 3

Targeting YAP Activity and Glutamine Metabolism Cooperatively Suppresses Tumor Progression by Preventing Extracellular Matrix Accumulation
Mihyang Park, Jonghwa Jin, D. An, et al.
Cancer Research (2024) Vol. 84, Iss. 20, pp. 3388-3401
Closed Access | Times Cited: 3

An immunotherapeutic hydrogel booster inhibits tumor recurrence and promotes wound healing for postoperative management of melanoma
Yuanyuan Yang, Bo Zhang, Yangtao Xu, et al.
Bioactive Materials (2024) Vol. 42, pp. 178-193
Open Access | Times Cited: 3

Macropinocytosis mediates resistance to loss of glutamine transport in triple-negative breast cancer
Kanu Wahi, Natasha Freidman, Qian Wang, et al.
The EMBO Journal (2024)
Closed Access | Times Cited: 3

Metabolic reprogramming by histone deacetylase inhibition preferentially targets NRF2-activated tumors
Dimitris Karagiannis, Warren Wu, Albert P. Li, et al.
Cell Reports (2023) Vol. 43, Iss. 1, pp. 113629-113629
Open Access | Times Cited: 8

ASCT2-mediated glutamine uptake of epithelial cells facilitates CCL5-induced T cell infiltration via ROS-STAT3 pathway in oral lichen planus
Jingyi Lu, Zhangci Su, Wei Li, et al.
International Immunopharmacology (2023) Vol. 119, pp. 110216-110216
Closed Access | Times Cited: 7

Metabolic Interplay in the Tumor Microenvironment: Implications for Immune Function and Anticancer Response
Reem Youssef, Rohan Maniar, Jaffar M. Khan, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 12, pp. 9753-9767
Open Access | Times Cited: 7

Design strategies and recent development of bioactive modulators for glutamine transporters
Xinying Cheng, Yezhi Wang, Guangyue Gong, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 2, pp. 103880-103880
Closed Access | Times Cited: 2

Metabolic Profiling to Assess Response to Targeted and Immune Therapy in Melanoma
Chantale Farah, Lionel Mignion, Bénédicte F. Jordan
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1725-1725
Open Access | Times Cited: 2

tRF-29-79 regulates lung adenocarcinoma progression through mediating glutamine transporter SLC1A5
Yuanjian Shi, Zehao Pan, Yipeng Feng, et al.
Carcinogenesis (2024) Vol. 45, Iss. 6, pp. 409-423
Closed Access | Times Cited: 2

Scroll to top